from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3107c/agpS

LFCtreatmentdescriptionclass of inhibitor

-0.285

Amikacinug/mL Amikacintranslation

-1.426

Cap5-10ug/mL Capreomycintranslation

-1.782

Rox10-50 ug/mL Roxithromycintranslation

-0.481

SM2-5 ug/mL Streptomycintranslation

-1.720

Tet5-10 ug/mL Tetracyclinetranslation

1.809

Rif0.2-5ug/mL Rifampicintranscription

0.433

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.470

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.501

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.217

CPZ10-50 ug/mL Chlorpromazinerespiration

0.297

Clofazimine10-13 ug/mL Clofaziminerespiration

0.497

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.310

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.411

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.225

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.599

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.117

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.556

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.352

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.165

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.055

KCN5-20 ug/mL Potassium cyaniderespiration

0.938

NaN30.2-2 mM Sodium aziderespiration

-1.839

Nigericin50 uM Nigericinrespiration

0.216

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.426

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.379

menadione6-10 ug/mL Menadionerespiration

-0.124

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.004

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.256

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.546

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.340

NRP_1Non-replicating persistence stage 1dosRassociated

-0.259

Amp0.2mg/mL AmpicillincellWall

0.555

Cephalexin20-100 ug/mL CephalexincellWall

-0.469

Cerulenin0.32-5 ug/mL CerulenincellWall

1.086

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.574

EMB10-20 ug/mL EthambutolcellWall

0.070

Eta12-40 ug/mL EthionamidecellWall

-0.085

INH0.2-0.4 ug/mL IsoniazidcellWall

0.082

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.485

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.456

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.214

BZA0.12 mg/mL BenzamidearomaticAmides

0.011

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.054

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.235

H2O24 mM hydrogen peroxideDNAdamaging

-0.297

Levo10 ug/mL LevofloxacinDNAdamaging

-0.703

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.072

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.224

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.917

UVUV-irradiationDNAdamaging

-0.051

ARP41-4 ug/mL Antitubercular compound ARP4?

0.898

Antimycin12.5-50 ug/mL Antimycin A?

-1.628

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.255

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.062

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.061

PA8240.2-2 ug/mL PA-824?

-0.043

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.022

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-2.153

mercaptoethanol2 mM 2-Mercaptoethanol?

0.425

methoxatin10-20 ug/mL Methoxatin?